Inozyme Pharma, Inc.
Institutional Ownership & Holdings Analysis
About
inozyme-pharma is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
| # | Institution | Value |
|---|---|---|
| 1 | EVENTIDE ASSET MANAGEMENT, LLC(2024-12-31) | $6.1M |
| 2 | ADAGE CAPITAL PARTNERS GP, L.L.C.(2025-03-31) | $4.7M |
| 3 | $4.1M | |
| 4 | Sofinnova Investments, Inc.(2025-03-31) | $3.9M |
| 5 | Affinity Asset Advisors, LLC(2025-03-31) | $3.5M |
| 6 | BlackRock, Inc.(2025-03-31) | $3.4M |
| 7 | Rock Springs Capital Management LP(2025-03-31) | $3.1M |
| 8 | VANGUARD GROUP INC(2025-03-31) | $2.5M |
| 9 | NEA Management Company, LLC(2025-03-31) | $2.2M |
| 10 | Samsara BioCapital, LLC(2025-03-31) | $1.4M |
| 11 | MILLENNIUM MANAGEMENT LLC(2025-03-31) | $1.1M |
| 12 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $1.1M |
| 13 | SPHERA FUNDS MANAGEMENT LTD.(2025-03-31) | $1.1M |
| 14 | FMR LLC(2025-03-31) | $1.1M |
| 15 | Blue Owl Capital Holdings LP(2025-03-31) | $982.8K |
| 16 | Woodline Partners LP(2025-03-31) | $913.4K |
| 17 | STATE STREET CORP(2025-03-31) | $907.4K |
| 18 | Nuveen Asset Management, LLC(2024-12-31) | $693.1K |
| 19 | Knott David M Jr(2025-03-31) | $606.2K |
| 20 | RENAISSANCE TECHNOLOGIES LLC(2025-03-31) | $513.7K |
As of 2024-12-31
Value:$6.1M
As of 2025-03-31
Value:$4.7M
As of 2025-03-31
Value:$4.1M
As of 2025-03-31
Value:$3.9M
As of 2025-03-31
Value:$3.5M
As of 2025-03-31
Value:$3.4M
As of 2025-03-31
Value:$3.1M
As of 2025-03-31
Value:$2.5M
As of 2025-03-31
Value:$2.2M
As of 2025-03-31
Value:$1.4M
As of 2025-03-31
Value:$1.1M
As of 2025-03-31
Value:$1.1M
As of 2025-03-31
Value:$1.1M
#14FMR LLC
As of 2025-03-31
Value:$1.1M
As of 2025-03-31
Value:$982.8K
As of 2025-03-31
Value:$913.4K
As of 2025-03-31
Value:$907.4K
As of 2024-12-31
Value:$693.1K
As of 2025-03-31
Value:$606.2K
As of 2025-03-31
Value:$513.7K
Total Institutional Holders:118
Top 10 Holders Own:68.4%